View the LUCIMAVA registration information details.
Back to drug list
ItemsDrug Registration information
ID1750
No1750
Brand NameLUCIMAVA
IngredientsMAVACAMTEN 2.5 MG
Dosage FormCAPSULE
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 60'S/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR THE TREATMENT OF ADULTS WITH SYMPTOMATIC NEW YORK HEART ASSOCIATION CLASS II-III OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY TO IMPROVE FUNCTIONAL CAPACITY AND SYMPTOMS
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionBLUE - WHITE CAPSULE CONTAINS WHITE POWDER
Note
License OwnerLUCIUS PHARMACEUTICALS(LAO) CO.,LTD
ManufacturerLUCIUS PHARMACEUTICALS(LAO) CO.,LTD
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No09 L 1198/24
FDD Registration Date24/09/2024
Expiry Date23/09/2029
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA